Insulet (PODD) Revenue — Quarter Ended Mar 31, 2025
Revenue decreased compared to the prior quarter but increased significantly versus the same period last year. The year-over-year growth remained robust despite the sequential decline.
Key takeaway
Quarter ended Mar 31, 2025 · FY2025 Q1
Revenue decreased compared to the prior quarter but increased significantly versus the same period last year. The year-over-year growth remained robust despite the sequential decline.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$569M
Revenue reported for this quarter.
Quarter-over-quarter
-4.8%
Change from the immediately preceding quarter.
Year-over-year
+28.8%
Change from the comparable year-ago quarter.
Trailing four quarters
$2.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2024 | $488.5M | +23.2% |
| Sep 30, 2024 | $543.9M | +25.7% |
| Dec 31, 2024 | $597.5M | +17.2% |
| Mar 31, 2025 | $569M | +28.8% |
Revenue performance
The reported revenue declined from the preceding quarter, reflecting a sequential contraction. However, on a year-over-year basis, revenue continued to expand at a strong pace.
Quarterly comparison
Compared to the immediately preceding quarter, revenue was lower, while compared to the same quarter one year earlier, it posted a substantial increase. These two contrasting movements highlight both short-term volatility and sustained long-term growth.
What to watch
Monitor whether the sequential decline is a temporary pause or signals a shift in demand trajectory.